tradingkey.logo

2Seventy Bio Inc <TSVT.OQ> expected to post a loss of 17 cents a share - Earnings Preview

ReutersApr 29, 2025 1:09 PM
  • 2Seventy Bio Inc TSVT.OQ TSVT.O is expected to show a rise in quarterly revenue when it reports results on May 1 (estimated) for the period ending March 31 2025

  • The Cambridge Massachusetts-based company is expected to report a 12.3% increase in revenue to $13.963 million from $12.44 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for 2Seventy Bio Inc is for a loss of 17 cents per share.

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts had fallen by about 20.9% in the last three months. ​

  • Wall Street's median 12-month price target for 2Seventy Bio Inc is $5.00​, above​ its last closing price of $4.99. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.20

-0.26

-0.37

Missed

-39.6

Sep. 30 2024

-0.23

-0.24

-0.19

Beat

21.2

Jun. 30 2024

-0.76

-0.65

0.45

Beat

169.5​

Mar. 31 2024

-0.79

-0.81

-1.01

Missed

-24.4

​​Dec. 31 2023

-1.05

-0.99

-1.11

Missed

-12.1

Sep. 30 2023

-1.20

-1.03

-1.00

Beat

2.8​

Jun. 30 2023

-1.09

-1.06

-0.83

Beat

22.1

Mar. 31 2023

-1.20

-1.19

-1.08

Beat

9.5

This summary was machine generated April 29 at 13:09 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI